USNA — Stock Film
STOCK FILMSCENE 1/11USNA · $22.40
Stock Expert AI presents
USNA
USANA Health Sciences, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
USANA Health Sciences, Inc. A quick introduction.

On the stock market since 1994, it operates in the everyday-essentials business. It has 1,570 employees. Now — the numbers.

on the stock market since 1994
1,570 employees
$413.6M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $1 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 1%

This is an established company with proven profits.

THE SALES TREND
Sales have been shrinking.

An average decline of 6% a year over the last 4 years — the most striking risk in this picture.

$1.2B
2021
$998.6M
2022
$921M
2023
$854.5M
2024
$925.3M
2026
Cash on hand:
$0
Total debt:
$0
The cash outweighs the debt.

If every debt were paid off today, $144.4M would still be left in the vault — a solid cushion for hard times.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
69
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
94
very strong

Debt is low and cash is strong; the finances stand solid.

VALUATION
93
very strong

The price looks reasonable next to what the company earns.

GROWTH
23
very weak

Clearly below the class average.

PRICE MOMENTUM
51
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 5 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
A strong cash pile8/10
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark3/10
Growth has stalled4/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 78% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Strong cash, light debt

There is $158.4M in the vault; even if every debt were paid off, $144.4M would remain.

2
THE BRIGHT SIDE · 2/2
Analysts’ target sits above today’s price

The average analyst price target is $35.0056% above today’s price.

1
THE RISKS · 1/2
Growth has stalled

Over the last 3 years, sales grew only 0% a year on average. At this size, speeding back up is not easy.

2
THE RISKS · 2/2
A rich price tag

The company’s market value is 38 times its annual profit. Even a small disappointment could hit the price hard.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, USNA sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: USNA is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film